The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-N-(2,3-Dihydro-1H-inden-5-yl)-3-(3,4,5-trimethoxyphenyl)acrylamide ID: ALA4533643
PubChem CID: 7920755
Max Phase: Preclinical
Molecular Formula: C21H23NO4
Molecular Weight: 353.42
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(/C=C/C(=O)Nc2ccc3c(c2)CCC3)cc(OC)c1OC
Standard InChI: InChI=1S/C21H23NO4/c1-24-18-11-14(12-19(25-2)21(18)26-3)7-10-20(23)22-17-9-8-15-5-4-6-16(15)13-17/h7-13H,4-6H2,1-3H3,(H,22,23)/b10-7+
Standard InChI Key: GROHDWUIKCNUKD-JXMROGBWSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
5.1632 -16.2118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8709 -15.8032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5786 -16.2118 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8709 -14.9860 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2863 -15.8032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9927 -16.2162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9877 -14.5818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2834 -14.9920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7003 -14.9902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7009 -15.8040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4751 -16.0550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9531 -15.3962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4742 -14.7382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4555 -15.8032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7477 -16.2118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0406 -15.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3334 -16.2080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3329 -17.0260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0456 -17.4345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7499 -17.0242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0485 -18.2516 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6258 -17.4356 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6259 -15.7990 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3422 -18.6627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9175 -17.0279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6263 -14.9818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 2 0
3 5 1 0
5 6 2 0
6 10 1 0
9 7 1 0
7 8 2 0
8 5 1 0
9 10 2 0
10 11 1 0
11 12 1 0
12 13 1 0
13 9 1 0
1 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
19 21 1 0
18 22 1 0
17 23 1 0
21 24 1 0
22 25 1 0
23 26 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 353.42Molecular Weight (Monoisotopic): 353.1627AlogP: 3.85#Rotatable Bonds: 6Polar Surface Area: 56.79Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.11CX LogD: 4.11Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.80Np Likeness Score: -0.47
References 1. Qiu Y, Xiao Z, Wang Y, Zhang D, Zhang W, Wang G, Chen W, Liang G, Li X, Zhang Y, Liu Z.. (2019) Optimization and anti-inflammatory evaluation of methyl gallate derivatives as a myeloid differentiation protein 2 inhibitor., 27 (20): [PMID:31466835 ] [10.1016/j.bmc.2019.115049 ]